These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 26244949)

  • 21. Paracetamol Accelerates Closure of the Ductus Arteriosus after Premature Birth: A Randomized Trial.
    Härkin P; Härmä A; Aikio O; Valkama M; Leskinen M; Saarela T; Hallman M
    J Pediatr; 2016 Oct; 177():72-77.e2. PubMed ID: 27215779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous paracetamol for PDA closure in the preterm: a single-center experience.
    Valerio E; Valente MR; Salvadori S; Frigo AC; Baraldi E; Lago P
    Eur J Pediatr; 2016 Jul; 175(7):953-66. PubMed ID: 27146832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
    Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
    Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
    Rajadurai VS; Yu VY
    J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for patent ductus arteriosus closure.
    Ferguson JM
    Congenit Heart Dis; 2019 Jan; 14(1):52-56. PubMed ID: 30536827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.
    Roofthooft DW; van Beynum IM; de Klerk JC; van Dijk M; van den Anker JN; Reiss IK; Tibboel D; Simons SH
    Eur J Pediatr; 2015 Nov; 174(11):1433-40. PubMed ID: 25922139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative safety and efficacy of paracetamol versus non-steroidal anti-inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta-analysis of randomized controlled trials.
    Katsaras DN; Katsaras GN; Chatziravdeli VI; Papavasileiou GN; Touloupaki M; Mitsiakos G; Doxani C; Stefanidis I; Dardiotis E
    Br J Clin Pharmacol; 2022 Jul; 88(7):3078-3100. PubMed ID: 35203104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
    Yadav S; Agarwal S; Maria A; Dudeja A; Dubey NK; Anand P; Yadav DK
    Pediatr Cardiol; 2014 Jun; 35(5):824-30. PubMed ID: 24435507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous acetaminophen (at 15 mg/kg/dose every 6 hours) in critically ill preterm neonates with patent ductus arteriosus: A prospective study.
    Sridharan K; Al Jufairi M; Al Ansari E; Al Marzooq R; Hubail Z; Hasan SJR; Al Madhoob A
    J Clin Pharm Ther; 2021 Aug; 46(4):1010-1019. PubMed ID: 33638909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions.
    Rostas SE; McPherson CC
    Curr Pediatr Rev; 2016; 12(2):110-9. PubMed ID: 27197952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants.
    Lee CH; Chen HN; Tsao LY; Hsiao CC; Lee ML
    Pediatr Neonatol; 2012 Dec; 53(6):346-53. PubMed ID: 23276438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials.
    Huang X; Wang F; Wang K
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2216-2222. PubMed ID: 28720053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis.
    Mitra S; Florez ID; Tamayo ME; Aune D; Mbuagbaw L; Veroniki AA; Thabane L
    BMJ Open; 2016 Jul; 6(7):e011271. PubMed ID: 27456327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous paracetamol with a lower dose is also effective for the treatment of patent ductus arteriosus in pre-term infants.
    Tekgündüz KŞ; Ceviz N; Caner İ; Olgun H; Demirelli Y; Yolcu C; Şahin İO; Kara M
    Cardiol Young; 2015 Aug; 25(6):1060-4. PubMed ID: 25160728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late medical therapy of patent ductus arteriosus using intravenous paracetamol.
    EL-Khuffash A; James AT; Cleary A; Semberova J; Franklin O; Miletin J
    Arch Dis Child Fetal Neonatal Ed; 2015 May; 100(3):F253-6. PubMed ID: 25653299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates.
    Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE
    J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.